Cocrystal Pharma Inc. Stock
Cocrystal Pharma Inc. Stock
Cocrystal Pharma Inc. shows a slight decrease today, losing -€0.005 (-0.560%) compared to yesterday.
The community is currently still undecided about Cocrystal Pharma Inc. with 2 Buy predictions and 0 Sell predictions.
With a target price of 5 € there is potential for a 458.66% increase which would mean more than doubling the current price of 0.9 € for Cocrystal Pharma Inc..
Our community identified positive and negative aspects for Cocrystal Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Cocrystal Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Cocrystal Pharma Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cocrystal Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc. | -0.560% | 2.874% | 0.000% | -51.359% | -69.138% | -65.970% | -94.127% |
| Pacira Pharmaceuticals | -1.890% | 2.970% | 5.584% | 12.432% | 12.432% | -52.294% | -55.172% |
| Rockwell Medical Inc. | 0.820% | -2.558% | -10.615% | -59.308% | -60.317% | -13.043% | -92.304% |
| Twist Bioscience Corp | 0.550% | 4.940% | 4.744% | -42.799% | -38.684% | 12.452% | -77.746% |
Comments
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $7.00 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $10.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat